Zuplenz

Indicated For

Chemotherapy-induced nausea and vomiting (CINV), Radiotherapy-induced nausea and vomiting (RINV), Postoperative nausea and vomiting (PONV)

About This Medication

# Aquestive Therapeutics Zuplenz Patient Assistance Guide: How to Get Zuplenz (ondansetron) at Low or No Cost Zuplenz (ondansetron) oral soluble film is a prescription medication used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. While Aquestive Therapeutics, the manufacturer, does not appear to offer a publicly detailed standalone patient assistance program (PAP) for Zuplenz based on available information, they provide support through their **Galena Patient Services (GPS) program**, which helps patients, prescribers, pharmacies, and insurers navigate access to the medication[2][3]. This guide explains what is known about eligibility, application processes, and alternatives to help you obtain Zuplenz at reduced or no cost. ## About Zuplenz (ondansetron) **Zuplenz** is an innovative oral soluble film that dissolves quickly on the tongue in about 10 seconds, without the need for water—ideal for patients experiencing nausea who struggle with swallowing pills[2][3][5]. It contains **ondansetron**, a well-established anti-nausea medication clinically bioequivalent to ondansetron orally disintegrating tablets, with the same safety profile[2][3]. Zuplenz is FDA-approved for: - Prevention of **chemotherapy-induced nausea and vomiting (CINV)** in adults (highly and moderately emetogenic) and children 4 years and older (moderately emetogenic)[2][3][5]. - **Radiotherapy-induced nausea and vomiting (RINV)** in adults[2][3][5]. - **Post-operative nausea and vomiting (PONV)** in adults[2][3][5]. Available in **4 mg and 8 mg strengths**, it's supplied nationwide and recommended by guidelines like the National Comprehensive Cancer Network (NCCN) for these conditions[2]. The PharmFilm® technology offers convenience, especially during treatment side effects or oral irritation[3][5]. Always consult your doctor for personalized advice, as ondansetron has contraindications (e.g., with apomorphine) and potential side effects like headache, constipation, or rare heart rhythm changes[5]. ## Who Qualifies for Assistance? Specific details on Aquestive's PAP, such as income thresholds, are not publicly available in current sources[1][2][3]. However, the **Galena Patient Services (GPS) program** assists with insurance navigation, prior authorizations, and access barriers, suggesting broad support for prescribed patients regardless of income[2]. Typical pharmaceutical PAPs target: - Uninsured or underinsured patients. - Those with limited income (often 400-500% of the Federal Poverty Level, or FPL). - U.S. residents without government insurance alternatives. Since exact criteria for Zuplenz are unavailable, contact GPS directly to check eligibility. General industry standards include households below these FPL thresholds (2026 estimates; verify current levels): | Household Size | Income Threshold (Approx. 400% FPL) | Notes | |---------------|-------------------------------------|-------| | 1 (Individual) | $60,000 | Annual gross income | | 2 (Couple) | $81,000 | May vary by program | | 3 | $102,000 | Excludes certain deductions | | 4 | $123,000 | Additional members +$21,000 | *Table based on standard PAP benchmarks; Aquestive-specific limits unknown.* ## Insurance Requirements GPS works directly with your **prescriber, insurance provider, and pharmacy** to facilitate coverage[2]. Programs like this often: - Accept patients with private insurance facing high copays. - Exclude those with Medicare, Medicaid, or other federal programs (though some offer copay assistance). - Require proof of benefits denial or high out-of-pocket costs. If insured, GPS may help with prior authorizations or appeals. Uninsured patients likely qualify for free or discounted supply if income-eligible[2]. ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor to prescribe Zuplenz and discuss GPS support[2]. 2. **Contact Galena Patient Services (GPS)**: Call the manufacturer hotline (find via aquestive.com or prescriber; phone: 908-941-1900 for general inquiries[7][9]). They guide uninsured/underinsured patients[2]. 3. **Submit Information**: Provide household income proof (tax returns, pay stubs), prescription, and insurance details (if any). No specific documents listed, but expect ID and residency proof[2]. 4. **Work with Your Team**: GPS coordinates with your pharmacy for delivery[2]. 5. **Follow Up**: Track status via phone; applications are typically processed quickly via their infrastructure[2]. Visit **aquestive.com** or **zuplenz.com** for updates[1][3]. ## Timeline and Delivery Processing time is not specified, but GPS leverages commercial infrastructure for efficient access post-prescription[2]. Expect medication shipped directly to your pharmacy or home, free of shipping costs if approved (standard for PAPs)[8]. Supplies may last 1-3 months initially, with reauthorization needed[6]. ## Alternatives if Denied or No Program Available - **Generic Ondansetron**: Cheaper tablets, ODTs, or films; bioequivalent to Zuplenz[2][3]. Ask your doctor about switching. - **Other PAPs**: Check NeedyMeds.org or RxAssist.org for ondansetron programs. - **Copay Cards**: Aquestive may offer savings for commercially insured (inquire via GPS). - **State Programs**: Medicaid, 340B clinics, or hospital charity care. - **Biosimilars**: None listed for ondansetron[provided data]. If denied, appeal with updated income proof or explore generics. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Aquestive's programs may change; **always verify directly with the manufacturer** at 908-941-1900 or aquestive.com[1][7]. Not medical advice—consult your healthcare provider. Eligibility not guaranteed; programs can discontinue[6]. Word count: 942.

Program information last verified: March 30, 2026